?

News

2026-05-07

Material Information- Announcement of the Board of Directors approved the consolidated financial statements for 2026 Q1.

1.Date of the board of directors submitted or approved:2026/05/07 2.Date of the audit committee approved:2026/05/07 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):2026/01/01~2026/03/31 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):209,615 5.Gross profit (loss) from operations accumulated from

2026-04-19

Material Information- Announces on behalf of the subsidiary Handa Oncology, LLC, regarding the 505(b)(2) new formulation drug HND-039 citizen petition to the FDA examination

1.Date of occurrence of the event:2026/04/17 2.Company name:Handa Oncology, LLC 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Subsidiaries 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence:The Company was informed on April 16, 2026 (U.S. time) that Handa Oncology, LLC (hereinafter referred to as “Handa Oncology”),an indirectly held subsidiary

2026-04-16

Material Information- Announcement of the Board’s Resolution to Repurchase Treasury Shares

1.Date of the board of directors resolution:2026/04/16 2.Purpose of the share repurchase:To maintain the Company’s credit and shareholders’ equity. 3.Type of shares to be repurchased:Common shares 4.Ceiling on total monetary amount of share repurchase (NTD):3,724,664,099 5.Scheduled period for the repurchase:2026/04/17~2026/06/16 6.No.of shares to be repurchased (shares):4,000,000 7.Repurchase price range (NTD):70.00~109.00, should

2026-03-31

Material Information- Announcement of the Completion of the Company’s Treasury Share Buyback

1.Originally prescribed ceiling on total monetary amount of share repurchase (NTD):3,087,249,414 2.Originally scheduled period for the repurchase:2026/02/12~2026/04/11 3.Originally determined no.of shares to be repurchased (shares):2,000,000 4.Originally determined repurchase price range (NTD):80.00~120.00 5.Actual period of the current repurchase:2026/02/25~2026/03/31 6.No.of shares currently repurchased (shares):2,000,000 7.Total monetary amount of shares currently repurchased (NTD):150,741,600 8.Current average

2026-03-18

Material Information- The Company was invited to attend the in-person and virtual institutional investor conference hosted by First Securities

1.Date of institutional investor conference:2026/04/14 2.Time of institutional investor conference:14:30 3.Location of institutional investor conference:2F., No. 35, Sec. 1, Chang’an E. Rd., Zhongshan Dist., Taipei City 4.Outline of institutional investor conference:(1)The Company was invited to attend the in-person and virtual institutional investor conference hosted by First Securities, to

2026-03-16

Material Information- Correction to the Material Information announced on March 12, 2026: Announcement of the newly appointed Chief Innovation Officer

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development officer, internal audit officer, or designated and non-designated representatives):Chief Innovation Officer 2.Date of occurrence of the

2026-03-12

Material Information- Announcement of the newly appointed Chief Innovation Officer

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development officer, internal audit officer, or designated and non-designated representatives):Chief Innovation Officer 2.Date of occurrence of the

2026-03-12

Material Information- Announcement of the change of internal audit officer

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development officer, internal audit officer, or designated and non-designated representatives):Internal audit officer 2.Date of occurrence of the

2026-03-12

Material Information- To convene the 2026 annual shareholders’ meeting.

1.Date of the board of directors' resolution：2026/03/12 2.Shareholders meeting date：2026/06/17 3.Shareholders meeting location：2F., No. 12, Zhouzi St., Neihu Dist., Taipei City, Taiwan 4.Shareholders' meeting will be held by means of (physical shareholders' meeting/ hybrid shareholders' meeting / virtual-only shareholders' meeting)：physical shareholders' meeting 5.Cause for convening the meeting (1)：Report item(s) (1)：2025